A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of MEDI5884 in Adults With Stable Coronary Heart Disease
Public ClinicalTrials.gov record NCT03351738. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2a Randomized, Double-blind, Placebo-controlled, Parallel-designed Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of MEDI5884 in Subjects With Stable Coronary Heart Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of MEDI5884 in Adults With Stable Coronary Heart Disease.
Study identification
- NCT ID
- NCT03351738
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 133 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 45 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 13, 2017 (Actual)
- Primary completion
- Nov 9, 2018 (Actual)
- Completion
- Nov 9, 2018 (Actual)
- Last update posted
- Mar 23, 2020
2017 – 2018
United States locations
- U.S. sites
- 23
- U.S. states
- 14
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Anniston | Alabama | 36207 | — |
| Research Site | Huntsville | Alabama | 35801 | — |
| Research Site | El Cajon | California | 92020 | — |
| Research Site | Lincoln | California | 95648 | — |
| Research Site | Northridge | California | 91325 | — |
| Research Site | Waterbury | Connecticut | 06708 | — |
| Research Site | Fleming Island | Florida | 32003 | — |
| Research Site | Jacksonville | Florida | 32216 | — |
| Research Site | Pembroke Pines | Florida | 33024 | — |
| Research Site | Port Orange | Florida | 32127 | — |
| Research Site | Savannah | Georgia | 31406 | — |
| Research Site | Evanston | Illinois | 60201 | — |
| Research Site | Indianapolis | Indiana | 46260 | — |
| Research Site | Louisville | Kentucky | 40213 | — |
| Research Site | Fargo | North Dakota | 58103 | — |
| Research Site | Cincinnati | Ohio | 45219 | — |
| Research Site | Marion | Ohio | 43302 | — |
| Research Site | Stow | Ohio | 44224 | — |
| Research Site | Oklahoma City | Oklahoma | 73134 | — |
| Research Site | Rapid City | South Dakota | 57701 | — |
| Research Site | Kingsport | Tennessee | 37660 | — |
| Research Site | McAllen | Texas | 78503 | — |
| Research Site | San Antonio | Texas | 78228 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03351738, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 23, 2020 · Synced Oct 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03351738 live on ClinicalTrials.gov.